Home » Topics » BioWorld Science

BioWorld Science
RSS

Arrowhead Pharmaceuticals initiates phase I study of ARO-ANG3

Dec. 27, 2018

FDA approves pediatric hexavalent combination vaccine Vaxelis

Dec. 27, 2018

Capricor places voluntary hold on phase II HOPE-2 study of CAP-1002

Dec. 27, 2018

Tyvyt approved in China for the treatment of Hodgkin's lymphoma

Dec. 27, 2018

ROMK inhibitors reported in Bristol-Myers Squibb patent

Dec. 27, 2018

Sunshine Lake Pharma reports agents for the treatment of HBV infections

Dec. 27, 2018

Positive data presented from dose-escalation portion of phase I study of TRC-105

Dec. 27, 2018

AbbVie licenses Lupin's MALT1 inhibitor program

Dec. 27, 2018

Mitophagy findings may offer new PD treatment promise

Dec. 27, 2018

TRACON Pharmaceuticals submits IND application for TJ-4309

Dec. 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...